{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:45:12Z","timestamp":1793738712567,"version":"4.6.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatology"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Recently metabolic dysfunction\u2013associated fatty liver disease (MAFLD) has been introduced and was defined as hepatic steatosis with either overweight, diabetes, and\/or a combination of other metabolic risk factors. We investigated the application of the MAFLD criteria as compared with NAFLD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Approach and Results<\/jats:title>\n                    <jats:p>\n                      We performed a cross\u2010sectional analysis within the Rotterdam Study, a large prospective population\u2010based cohort. Participants who attended the liver ultrasound and transient elastography program between 2009 and 2014 were eligible for inclusion. Subsequently, individuals with viral hepatitis, alcohol intake &gt;60 g\/day, missing alcohol data, and\/or missing body mass index were excluded. According to their NAFLD and MAFLD status based on metadata and ultrasound, participants were allocated in overlap fatty liver disease (FLD), NAFLD\u2010only, MAFLD\u2010only, or no FLD. Fibrosis was defined as liver stiffness \u22658.0 kPa. In our analysis, 5445 participants were included: 1866 (34.3%) had MAFLD and 1604 (29.5%) [Correction added on December 27, 2021 after first online publication: The preceding fragment was changed from \u201c1623 (29.8%)\u201d] had NAFLD. This resulted in 1547 (28.4%) [Correction added on December 27, 2021 after first online publication: The preceding fragment was changed from \u201c1566 (28.8%)\u201d] individuals with overlap FLD, 319 (5.9%) [Correction added on December 27, 2021 after first online publication: The preceding fragment was changed from \u201c300 (5.5%)\u201d] with MAFLD\u2010only, 57 (1.0%) with NAFLD\u2010only, and 3522 (64.7%) with no FLD. The MAFLD\u2010only group was strongly associated with fibrosis (adjusted OR 5.30 [Correction added on December 27, 2021 after first online publication: The preceding fragment was changed from \"OR 5.27\"],\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u00a0&lt;\u00a00.001) and log\u2010transformed liver stiffness (adjusted beta 0.116,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001), as opposed to the NAFLD\u2010only group, in which no cases of fibrosis were identified and no association with liver stiffness (adjusted beta 0.006,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      = 0.90) was found.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>FLD is highly prevalent in the general population. However, not the NAFLD\u2010only, but the MAFLD\u2010only group was associated with fibrosis and higher liver stiffness\u2014independent of demographic and lifestyle factors. We believe that using the MAFLD criteria will help improve the identification and treatment of patients with FLD at risk for fibrosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/hep.32131","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T02:55:01Z","timestamp":1630119301000},"page":"419-429","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":88,"title":["Metabolic dysfunction\u2013associated fatty liver disease improves detection of high liver stiffness: The Rotterdam Study"],"prefix":"10.1097","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-1182","authenticated-orcid":false,"given":"Laurens A.","family":"van Kleef","sequence":"first","affiliation":[{"name":"Departments of Gastroenterology and Hepatology,Erasmus MC University Medical Center,Rotterdam,the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8197-3458","authenticated-orcid":false,"given":"Ibrahim","family":"Ayada","sequence":"additional","affiliation":[{"name":"Departments of Gastroenterology and Hepatology,Erasmus MC University Medical Center,Rotterdam,the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7342-4654","authenticated-orcid":false,"given":"Louise J.M.","family":"Alferink","sequence":"additional","affiliation":[{"name":"Departments of Gastroenterology and Hepatology,Erasmus MC University Medical Center,Rotterdam,the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-6184","authenticated-orcid":false,"given":"Qiuwei","family":"Pan","sequence":"additional","affiliation":[{"name":"Departments of Gastroenterology and Hepatology,Erasmus MC University Medical Center,Rotterdam,the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0934-6975","authenticated-orcid":false,"given":"Robert J.","family":"de Knegt","sequence":"additional","affiliation":[{"name":"Departments of Gastroenterology and Hepatology,Erasmus MC University Medical Center,Rotterdam,the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"key":"hep32131-bib-0001-20250824","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014meta\u2010analytic assessment of prevalence, incidence, and outcomes","volume":"64","year":"2016","journal-title":"Hepatology"},{"key":"hep32131-bib-0002-20250824","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"hep32131-bib-0003-20250824","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-48382-5_1","article-title":"The definition and prevalence of obesity and metabolic syndrome","volume":"960","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"hep32131-bib-0004-20250824","doi-asserted-by":"crossref","first-page":"100192","DOI":"10.1016\/j.jhepr.2020.100192","article-title":"NAFLD and liver transplantation: disease burden, current management and future challenges","volume":"2","year":"2020","journal-title":"JHEP Reports"},{"key":"hep32131-bib-0005-20250824","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s10620-019-05986-9","article-title":"Impact of NAFLD on the incidence of cardiovascular diseases in a primary care population in germany","volume":"65","year":"2020","journal-title":"Dig Dis Sci"},{"key":"hep32131-bib-0006-20250824","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non\u2010alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta\u2010analysis","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"hep32131-bib-0007-20250824","article-title":"Non\u2010alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults","volume":"367","year":"2019","journal-title":"BMJ"},{"key":"hep32131-bib-0008-20250824","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/dom.14322","article-title":"Nonalcoholic fatty liver disease as a metabolic disease in humans: a literature review","volume":"23","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"hep32131-bib-0009-20250824","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic associated fatty liver disease: an international expert consensus statement","volume":"73","year":"2020","journal-title":"J Hepatol"},{"key":"hep32131-bib-0010-20250824","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus\u2010driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","year":"2020","journal-title":"Gastroenterology"},{"key":"hep32131-bib-0011-20250824","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jhep.2021.01.022","article-title":"Capturing patient experience: a qualitative study of change from NAFLD to MAFLD real\u2010time feedback","volume":"74","year":"2021","journal-title":"J Hepatology"},{"key":"hep32131-bib-0012-20250824","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","year":"2020","journal-title":"Liver Int"},{"key":"hep32131-bib-0013-20250824","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","year":"2020","journal-title":"Liver Int"},{"key":"hep32131-bib-0014-20250824","article-title":"Outcomes of NAFLD and MAFLD: results from a community\u2010based, prospective cohort study","volume":"16","year":"2021","journal-title":"PLoS One"},{"key":"hep32131-bib-0015-20250824","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cgh.2020.10.046","article-title":"Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease","volume":"19","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32131-bib-0016-20250824","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10654-020-00640-5","article-title":"Objectives, design and main findings until 2020 from the Rotterdam Study","volume":"35","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"hep32131-bib-0017-20250824","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines for the management of non\u2010alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"hep32131-bib-0018-20250824","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1111\/j.1572-0241.2007.01526.x","article-title":"The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation","volume":"102","year":"2007","journal-title":"J Am Coll Gastroenterol"},{"key":"hep32131-bib-0019-20250824","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/hep.25993","article-title":"Determination of reliability criteria for liver stiffness evaluation by transient elastography","volume":"57","year":"2013","journal-title":"Hepatology"},{"key":"hep32131-bib-0020-20250824","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/gut.2010.221382","article-title":"Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community\u2010based population aged over 45 years","volume":"60","year":"2011","journal-title":"Gut"},{"key":"hep32131-bib-0021-20250824","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta\u2010cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","year":"1985","journal-title":"Diabetologia"},{"key":"hep32131-bib-0022-20250824","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome","volume":"112","year":"2005","journal-title":"Circulation"},{"key":"hep32131-bib-0023-20250824","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","article-title":"Prevalence and risk factors of non\u2010alcoholic fatty liver disease in the elderly: results from the Rotterdam study","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"hep32131-bib-0024-20250824","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3390\/ijerph17061818","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease in Xinxiang, China","volume":"17","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"hep32131-bib-0025-20250824","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","article-title":"Metabolic dysfunction\u2010associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study","volume":"19","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"hep32131-bib-0026-20250824","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","year":"2008","journal-title":"Nat Genet"},{"key":"hep32131-bib-0027-20250824","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","year":"2009","journal-title":"Diabetologia"},{"key":"hep32131-bib-0028-20250824","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1074\/jbc.M116.719955","article-title":"Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins","volume":"291","year":"2016","journal-title":"J Biol Chem"},{"key":"hep32131-bib-0029-20250824","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta\u2010analysis","volume":"54","year":"2011","journal-title":"Hepatology"},{"key":"hep32131-bib-0030-20250824","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/liv.14301","article-title":"Liver stiffness measurement predicts long\u2010term survival and complications in non\u2010alcoholic fatty liver disease","volume":"40","year":"2020","journal-title":"Liver Int"},{"key":"hep32131-bib-0031-20250824","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non\u2010invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"hep32131-bib-0032-20250824","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","article-title":"The role of bright liver echo pattern on ultrasound B\u2010mode examination in the diagnosis of liver steatosis","volume":"38","year":"2006","journal-title":"Dig Liver Dis"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.32131","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep.32131","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T23:00:28Z","timestamp":1756076428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep.32131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,13]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.32131","relation":{},"ISSN":["0270-9139","1527-3350"],"issn-type":[{"value":"0270-9139","type":"print"},{"value":"1527-3350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,13]]},"assertion":[{"value":"2021-04-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}